Investor Relations contacts
Use a maximum of two downloads here
Home / Investor Relations / Investor Relations contacts
Contact Investor Relations
Joris Silon
Head of Investor Relations
Christer Gruvris
Executive Director of Investor Relations
BioPharmaceuticals (Cardiovascular, Renal and Metabolism), Finance & Fixed Income
Philip Sparks
Director of Investor Relations
BioPharmaceuticals (Vaccines & Immune Therapies) and Sustainability
Andrew Christmas
Director of Investor Relations
BioPharmaceuticals (Respiratory & Immunology)
Isabel Gibson
Director of Investor Relations
Oncology
Louise Pearson
Director of Investor Relations
Oncology
Lauren Swales
Director of Investor Relations
Rare Disease
Contact us on:
Shareholder Registrar Information
UK Registrar – Computershare Investor Services PLC
+44 (0) 370 707 1682 (International)
US Registrar and Transfer Agent – Computershare Investor Services
+1 (781) 575-2844 (International)
TR1 notifications
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
